Clene (NASDAQ:CLNN) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.66) by 4.55 percent. This is a 666.67 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $15.000 thousand which missed the analyst consensus estimate of $35.064 thousand by 57.22 percent. This is a 81.48 percent decrease over sales of $81.000 thousand the same period last year.